[1] Petersen JB,Lassen Y,Hansen A,et al. Normal liver tissue sparing by internsity-modulated proton stereotatic body radiotherapy for solitary liver tumors[J]. Acta Oncol,2011,50(6):823-828. [2] Lee MT,Kim JJ,Dinniwell R,et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases[J].J Clin Oncol,2009,27(10):1585-1591. [3] Dawood O,Mahadevan A,Karyn A,et al. Stereotactic body radiation therapy for liver metastases[J].Eur J Cancer,2009,45(17):2947-2959. [4] Herfarth KK,Debus J,Lohr F,et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial[J].J Clin Oncol,2001,19(1):164-170. [5] Hoyer M,Roed H,Traberg-Hansen A,et al. Phase II study on stereotactic body radiotherapy of colorectal metastases[J].Acta Oncol,2006,45(7):823-830. [6] Katz AW,Carey-Sampson M,Muhs AG,et al. Hypofractionated stereotactic body radiation therapy(SBRT) for limited hepatic metastases[J]. Int J Radiat Oncol Biol Phys,2007,67(3):793-798. [7] Lee MT,Kim JJ,Dinniwell R,et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases[J]. J Clin Oncol,2009,27(10):1585-1561. [8] Rusthoven KE,Kavanagh BD,Cardenes H,et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases[J]. J Clin Oncol,2009,27(10):1572-1578. [9] Wulf J,Guckenberger M,Haedinger U,et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases[J]. Acta Oncol,2006,45(7):838-847. [10] Chang DT,Swaninath A,Kozak M,et al. Stereotactic body radiation therapy for liver metastases:a pooled analysis[J]. Cancer,2011,117(17):4060-4069. [11] Schefter NE,Kavanagh BD,Timmerman RD,et al. A phase I trial of stereotactiv body radiation therapy(SBRT) for liver metastases[J]. Int J Radiat Oncol Biol Phys,2005,62(5):1371-1378. [12] Dawson LA,Ten Haken R. Partial volume tolerance of the liver to radiation[J]. Semin Radiat Oncol,2005,15(4):279-283. [13] Wulf J,Hadinger U,Oppitz U,et al. Stereotactic radiotherapy of targets in the lung and liver[J]. Strahlenther Onkol,2001,177(12):645-655. [14] Goodman KA,Wiegner EA,Maturen KE,et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies[J]. Int J Radiat Oncol Biol Phys,2010,78(2):486-493. [15] 蒋国梁.原发性肝癌的三维适形放疗八年研究的总结[A]//中华医学会放射肿瘤治疗学分会.2007第六届全国放射肿瘤学学术年会论文集[C].北京:中华医学会放射肿瘤治疗学分会,2007:9-19. [16] Kavanagh BD,McGarry RC,Timmerman RD. Extracranial radiosurgery(stereotactic body radiation therapy) for Oligometastases[J].Semin Radiat Oncol,2006,16(2):77-84. [17] Heinzerling JH,Anderson JF,Papiez L,et al. Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver[J]. Int J Radiat Oncol Biol Phys,2008,70(5):1571-1578. [18] Eccles C,Brock KK,Bissonnette JP,et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy[J]. Int J Radiat Oncol Biol Phys,2006,64(3):751-759. [19] Guckenberger M,Krieger T,Richter A,et al. Potential of image-guidance,gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy[J]. Radiother Oncol,2008,91(3):288-295. [20] Wurm RE,Gum F,Erbel S,et al. Image guided respiratory gated hypofractionated stereotactic body radiation therapy(H-SBRT) for liver and lung tumors: initial experience[J]. Acta Oncol,2006,45(7):881-889. [21] Korreman SS,Juhler-Nottrup T,Boyer AL,et al. Respiratory gated beam delivery cannot facilitate margin reduction,unless combined with respiratory correlated image guidance[J]. Radiother Oncol,2008,86(1):61-68. [22] Hyer M,Swaminath A,Bydder S,et al. Radiotherapy for liver metastases: a review of evidence[J].Int J Radiat Oncol Biol Phys,2012,82(3):1047-1057. [23] Herfarth KK,Debus J,Wannenmacher M,et al. Stereotactic radiation therapy of liver metastases:update of the initial phase-I/II trial[J]. Front Radiat Ther Oncol,2004,38:100-105. [24] Bae SH,Kim MS,Cho CK,et al. High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases[J].Surg Oncol,2012,106(2):138-143. [25] Mendez-Romero A,Wunderink W,Hussain SM,et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study[J]. Acta Oncol,2006,45(7):831-837. [26] Ambrosino G,Polistina F,Costantin G,et al. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results[J]. Anticancer Res,2009,29(8):3381-3384. [27] Bautravers-Dewas C,Dewas S,Bonodeau F,et al.Image-Guided robotic stereotactic body radiation therapy for liver metastases:is there a dose response relationship[J].Int J Radiat Oncol Biol Phys,2011,81(3):39-47. [28] Schefter TE,Kavanagh BD,Timmerman RD,et al. A phase I trial of stereotactic body radiation therapy(SBRT) for liver metastases[J]. Int J Radiat Oncol Biol Phys,2005,62(5):1371-1378. [29] Karyn A,Ellen A,Katherine E. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies[J]. Int J Radiat Oncol Biol Phys,2010,78(2):486-493. [30] Sato M,Uematsu M,Yamamoto F,et al.Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer[J]. J Radiosurg,1998,1(1):233-238. [31] Pan C,Kavanagh B,Dawson L,et al. Radiation-associated liver injury[J]. Int J Radiat Oncol Biol Phys,2010,76(3):94-100. [32] Dawson LA,Normolle D,Balter JM,et al. Analysis of radiation-induced liver disease using the Lyman NTCP model[J]. Int J Radiat Oncol Biol Phys,2002,53(4):810-821. [33] Schefter TE,Welsh J,Gaspar LE,et al. Normal liver V30% and mean liver dose predicts the maximum normal liver volume reduction after stereotactic body radiation therapy(SBRT)[J]. Int J Radiat Oncol Biol Phys,2007,69(3):596-596. [34] Blomgren H,Lax I,Goranson H,et al. Radiosurgery for tumors in the body: clinical experience using a new method[J]. J Radiosurg,1998,1(1):63-74. [35] Tse RV,Hawkins M,Lockwood G,et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. J Clin Oncol,2008,26(4):657-664. [36] Kavanagh BD,Schefter TE,Cardenes HR,et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases[J]. Acta Oncol,2006,45(7):848-855. [37] Dunlap NE,Cai J,Biedermann GB,et al.Chestwall volume receiving>30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy[J].Int J Radiat Oncol Biol Phys,2010,76(3):796-801. [38] Kim M,Son SH,Won YK,et al. Stereotactic ablative radiotherapy for oligometastatic disease in liver[J].Biomed Res Int,2014,340478[2014-05-04].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020541/. [39] Nair VJ,Pantarotto JR. Treatment of metastatic liver tumors using stereotactic ablative radiotherapy[J].World J Radiol,2014,6(2):18-25.
2015, Vol. 24 
